Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Long-term efficiency of intravenously administered immunoglobulin in anti-Yo syndrome with paraneoplastic cerebellar degeneration.

× No keyword cloud information.

17 in total

1. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients.

Authors: F Graus; F Keime-Guibert; R Reñe; B Benyahia; T Ribalta; C Ascaso; G Escaramis; J Y Delattre
Journal: Brain Date: 2001-06 Impact factor: 13.501

2. Successful treatment of paraneoplastic cerebellar degeneration with Rituximab.

Authors: Marcello Esposito; P Penza; G Orefice; A Pagano; E Parente; A Abbadessa; V Bonavita
Journal: J Neurooncol Date: 2007-10-09 Impact factor: 4.130

3. Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies.

Authors: M Uchuya; F Graus; F Vega; R Reñé; J Y Delattre
Journal: J Neurol Neurosurg Psychiatry Date: 1996-04 Impact factor: 10.154

4. Neurologic improvement after high-dose intravenous immunoglobulin therapy in patients with paraneoplastic cerebellar degeneration associated with anti-Purkinje cell antibody.

Authors: Surasak Phuphanich; Charles Brock
Journal: J Neurooncol Date: 2006-06-14 Impact factor: 4.130

5. Reversal of subacute paraneoplastic cerebellar syndrome with intravenous immunoglobulin.

Authors: C E Counsell; M McLeod; R Grant
Journal: Neurology Date: 1994-06 Impact factor: 9.910

6. Early diagnosis and intravenous immune globulin therapy in paraneoplastic cerebellar degeneration.

Authors: J W Moll; S C Henzen-Logmans; F G Van der Meché; C H Vecht
Journal: J Neurol Neurosurg Psychiatry Date: 1993-01 Impact factor: 10.154

7. Intravenous immunoglobulins in the therapy of paraneoplastic neurological disorders.

Authors: F Blaes; M Strittmatter; S Merkelbach; V Jost; M Klotz; K Schimrigk; G F Hamann
Journal: J Neurol Date: 1999-04 Impact factor: 4.849

8. Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone.

Authors: F Keime-Guibert; F Graus; A Fleury; R René; J Honnorat; P Broet; J Y Delattre
Journal: J Neurol Neurosurg Psychiatry Date: 2000-04 Impact factor: 10.154

9. An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes.

Authors: Setareh Shams'ili; Janet de Beukelaar; Jan Willem Gratama; Herbert Hooijkaas; Martin van den Bent; Mars van 't Veer; Peter Sillevis Smitt
Journal: J Neurol Date: 2006-01 Impact factor: 4.849

10. Autoimmune paraneoplastic cerebellar degeneration in ovarian carcinoma patients treated with plasmapheresis and immunoglobulin. A case report.

Authors: Y B David; E Warner; M Levitan; D M Sutton; M G Malkin; J O Dalmau
Journal: Cancer Date: 1996-11-15 Impact factor: 6.860

5 in total

1. Paraneoplastic neurological syndromes: general treatment overview.

Authors: Aurélien Viaccoz; Jérôme Honnorat
Journal: Curr Treat Options Neurol Date: 2013-04 Impact factor: 3.598

2. Early-onset immunotherapy by intravenous immunoglobulin and corticosteroids in well characterized onconeural-antibody-positive paraneoplastic neurological syndrome.

Authors: J Honnorat
Journal: Clin Exp Immunol Date: 2014-12 Impact factor: 4.330

Long-term efficiency of intravenously administered immunoglobulin in anti-Yo syndrome with paraneoplastic cerebellar degeneration.